Definitive Healthcare Corp Reports Q2 Financial Results for Period Ending June 30 2024

authorIntellectia.AI2024-08-08
5
DH.O
Illustration by Intellectia.AI

Definitive Healthcare Corp. Reports Q2 Financial Results for Period Ending June 30, 2024

Overview

Definitive Healthcare Corp. has reported its financial results for the second quarter ended June 30, 2024.

Key Financial Metrics

The following table summarizes key financial metrics:

Metric Q2 2023 Q2 2024 YoY Change Wall Street Consensus (Q2 2024) Performance vs. Consensus
Total Revenue $61.7M $64.5M +4.5% $63.16M Exceeded
Earnings Per Share (EPS) $(0.08) $(2.72) N/A $0.09 Below

Interpretation : Definitive Healthcare Corp. reported a revenue of $64.5M for Q2 2024, slightly exceeding the Wall Street consensus estimate of $63.16M. However, the company posted an EPS of $(2.72), significantly below the projected $0.09 due to a goodwill impairment charge.

Dividends and Share Repurchase Program

During the quarter, Definitive Healthcare Corp. repurchased 1,258,565 shares of its Class A Common Stock for $7.0 million under a stock repurchase program authorized by the company’s Board of Directors. No dividends were announced.

Stock Price Movement

The stock price of Definitive Healthcare Corp. declined by 4.05% following the earnings release.

This article provides a concise summary of the recently reported financial results for Definitive Healthcare Corp., highlighting key financial metrics, shareholder activity, and the resulting stock price movement.

Share